Market Cap

Guangdong Hybribio Biotech Co.,Ltd. Market Capitalization:

CN¥3.07 Billion

CNY as of July 1, 2024

US$422.6 Million

business Guangdong Hybribio Biotech Co.,Ltd. Company Profile

Guangdong Hybribio Biotech Co.,Ltd. Main Stock Listing

SZSE: 300639

Market Capitalization History of Guangdong Hybribio Biotech Co.,Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $204.45 B
Danaher $177.21 B
Siemens Healthineers AG $63.84 B
DexCom, Inc. $45.21 B
Lonza Group Ltd $39.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Guangdong Hybribio Biotech Co.,Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2024 CN¥5.86 B -23.44%
Jan. 1, 2023 CN¥7.66 B -4.73%
Jan. 1, 2022 CN¥8.04 B -9.79%
Jan. 1, 2021 CN¥8.91 B 32.47%
Jan. 1, 2020 CN¥6.73 B 155.14%
Jan. 1, 2019 CN¥2.64 B -47.83%
Jan. 1, 2018 CN¥5.05 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Guangdong Hybribio Biotech Co.,Ltd. Categories

Hong Kong languages Healthcare languages Diagnostics & Research
Hong Kong Healthcare Hong Kong Diagnostics & Research

Stocks & Indices

Guangdong Hybribio Biotech Co.,Ltd. has the following listings and related stock indices.


Stock: SZSE: 300639

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.